APA (7th ed.) Citation

MD, W., T, N., JP, N., C, S., AM, R., P, A., . . . KJ, N. (2021). Post-treatment hypermutation in a recurrent diffuse glioma with H3.3 p.G34 Mutation. Neuropathology and applied neurobiology, 47(3), 460. https://doi.org/10.1111/nan.12679

Chicago Style (17th ed.) Citation

MD, Wood, Neff T, Nickerson JP, Sayama C, Raslan AM, Ambady P, Corless CL, and Nazemi KJ. "Post-treatment Hypermutation in a Recurrent Diffuse Glioma with H3.3 P.G34 Mutation." Neuropathology and Applied Neurobiology 47, no. 3 (2021): 460. https://doi.org/10.1111/nan.12679.

MLA (9th ed.) Citation

MD, Wood, et al. "Post-treatment Hypermutation in a Recurrent Diffuse Glioma with H3.3 P.G34 Mutation." Neuropathology and Applied Neurobiology, vol. 47, no. 3, 2021, p. 460, https://doi.org/10.1111/nan.12679.